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Elemental vs. phase composition of 
breast calcifications
Robert Scott  1,2, Catherine Kendall1, Nicholas Stone3 & Keith Rogers2
Despite the importance of calcifications in early detection of breast cancer, and their suggested role in 
modulating breast cancer cell behaviour, very little detail is known about their chemical composition 
or how this relates to pathology. We measured the elemental composition of calcifications contained 
within histological sections of breast tissue biopsies, and related this to both crystallographic 
parameters measured previously in the same specimens, and to the histopathology report. The Ca:P 
ratio is of particular interest since this theoretically has potential as a non-invasive aid to diagnosis; this 
was found to lie in a narrow range similar to bone, with no significant difference between benign and 
malignant. The Mg:Ca ratio is also of interest due to the observed association of magnesium whitlockite 
with malignancy. The initially surprising inverse correlation found between whitlockite fraction and 
magnesium concentration can be explained by the location of the magnesium in calcified tissue. 
Sodium was also measured, and we discovered a substantial and significant difference in Na:Ca ratio in 
the apatite phase between benign and malignant specimens. This has potential for revealing malignant 
changes in the vicinity of a core needle biopsy.
This study extends our earlier work investigating the crystallographic properties of breast calcifications, and its 
relationship with pathology1. Elemental composition is of interest for two main reasons.
Firstly, variation of composition with pathology could in principle be used to improve diagnosis. The charac-
teristics currently employed to distinguish suspicious from benign calcifications in screening mammography are 
based on radiographic appearance, such as size, shape, and distribution. Despite the existence of well-developed 
radiographic risk scoring systems based on these characteristics, such as BI-RADS2, the most recent published 
results from the NHS England screening programme show that only 21% women referred for further assess-
ment following screening subsequently receive a diagnosis of cancer3. There is therefore a clear clinical need for 
improvement of the positive predictive value of mammography. If predictive aspects of the chemical composition 
could be determined radiographically and overlaid on a mammogram, that could give valuable extra information 
to assist the radiologist with assessment. It could be likened to viewing the calcifications present on a mam-
mogram in colour rather than black and white. In theory, it is possible to differentiate between calcified tissues 
with a dissimilar calcium to phosphorus ratio using dual energy radiography, and this has been demonstrated 
in-vivo4. In addition, a simulation study suggested that it is theoretically possible to use dual energy imaging to 
discriminate Type 1 (calcium oxalate) from the more common Type 2 (hydroxyapatite) calcifications in breast 
tissue5. The technological challenges for practical implementation are formidable, particularly for discrimination 
of more subtle changes in Ca:P ratio within Type 2 calcifications. However, advances in detector technology, such 
as energy resolving photon-counting detectors, give some cause for optimism. In order for these measurements 
to be clinically useful, there does need to be a detectable difference in elemental composition between calcifica-
tions in benign and malignant cases. A principal aim of this study was therefore to determine whether there is a 
sufficient variation in Ca:P ratio with pathology for this to have diagnostic potential.
Secondly, there is also increasing evidence that calcifications are not passive bystanders, but can play an active 
role in breast cancer progression6–8. The importance of calcifications as part of the breast cancer microenvi-
ronment is perhaps not surprising, given that calcified tissue forms fertile ‘soil’ for breast cancer metastasis, as 
was pointed out by Stephen Paget in 18899. There is also evidence that breast cancer cell behaviour depends on 
the characteristics of the hydroxyapatite crystallites10. Despite this, current understanding of breast calcification 
chemistry is very sketchy.
Early studies on the composition of breast calcifications classified them into two distinct chemical and crys-
tallographic types. “Type 1” calcifications are composed of calcium oxalate in the crystalline form of weddellite; 
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these are comparatively uncommon, and are believed to be the result of benign processes. “Type 2” calcifications 
are composed of calcium phosphate with an apatite structure; these are much more common, and are some-
times, but not always, the result of malignancy. Subsequent work has shown that Type 2 calcifications are rather 
variable in composition and structure. Some aspects of this physico-chemical variability are related to pathol-
ogy, and could be diagnostically useful. For instance, a strong correlation has been found between carbonate 
substitution and pathology classification11, 12, and this could in principle be probed non-invasively using Raman 
Spectroscopy13. Microstructure of other pathological calcifications has also been shown to have potential for 
determining aetiology14. Breast calcifications also exhibit microstructural variations, such as a spherulitic struc-
ture that appears be related to malignancy15.
There are theoretical reasons why the elemental composition of calcifications may differ between calcifica-
tions of benign and malignant origin. A very wide range of ions can be incorporated as substitutions within the 
hydroxyapatite lattice16. The extent of substitution, and hence the elemental composition, depend on the ionic 
environment as calcifications form. This is similar to the way that precipitated apatitic biomaterials with a con-
trolled range of substitutions can be synthesised by varying reagent composition. There are several proposed ini-
tiation sites for the formation of breast calcifications, including apoptotic bodies, matrix vesicles, and extracellular 
matrix, or possibly a combination8. Both intracellular and extracellular ionic concentrations can be substantially 
altered in tumour tissue as a result of metabolic changes that affect ion transport across the cell membrane. For 
instance, elevated intracellular sodium and magnesium are associated with mitogenesis and markedly high levels 
are seen in tumour cells17–20. Breast tumour soft tissue has also been shown to be enriched in potassium, calcium, 
iron, copper, and zinc21, 22. It is unclear whether there are similar patterns of element enrichment and depletion 
in calcifications associated with tumours. Our earlier study showed a variation in crystallographic parameters 
of hydroxyapatite with pathology, and that malignancy is associated with the presence of increased quantities of 
magnesium whitlockite. These both provide indirect evidence for variation in elemental composition with pathol-
ogy, which we sought to confirm by direct measurement of the same set of biopsy specimens.
Diagnostic archives offer ready access to a wide range of specimens, but there are few suitable techniques 
for analysis of the elemental composition of a calcification within a histological section. We chose to use 
Energy-dispersive X-ray spectroscopy in a scanning electron microscope (SEM-EDS), since it is well suited to 
measurement of major elements in calcified tissue of a few micrometres thick (typical of breast tissue histolog-
ical sections). In addition, it offers excellent spatial resolution, and is readily available. X-ray fluorescence is an 
alternative, but has much poorer spatial resolution, and with calcified tissue of a few micrometres thick, the ele-
mental signals are strongly dependent on thickness, which makes quantitative analysis difficult or impossible in 
specimens of uneven thickness over the irradiated area. It should be noted that quantitative analysis of this type of 
specimen by SEM-EDS does have many potential pitfalls, which are addressed in the methods section.
Results
Calcfication Morphology. An SEM-EDS image of a typical calcification is shown in Fig. 1. Although the 
calcification has been fragmented by sectioning, it remains essentially complete. As discussed in the methods 
section, a few calcifications were extensively disrupted by the microtome blade. An example is shown in Fig. 2. 
These calcifications were generally characterised by a wider confidence interval for the median of measured 
composition.
Calcium Phosphorus Ratio. All bar one of the calcifications had a measured atomic Ca:P ratio in the range 
of 1.54 to 1.92, with a mean and median of 1.70. The one Ca:P outlier consisted of a small (~Ø70 μm) calcification 
in an invasive specimen, in which the Ca:P measurements fell into two very distinct groups: 15 point measure-
ments had a measured Ca:P ratio >100, and 12 measurements had a Ca:P ratio in the normal range (median 
1.78). The normal and low-phosphorus measurements were in discrete areas, as shown by the calcium and phos-
phorus maps in Fig. 3. Although an isolated occurrence, the measurements from this calcification proved impor-
tant in interpreting the results with minor elements.
The relationship between pathology and the Ca:P ratio, averaged by calcification, is shown in Fig. 4. The mean 
Ca:P ratio was 1.70, 1.69 and 1.70 for benign, in-situ, and invasive respectively. In addition, the apparent differ-
ence in variance between pathology groups was not found to be significant (Brown-Forsythe test).
Magnesium Calcium Ratio. The mean Mg:Ca atomic ratio was calculated as 1.93% (95% confidence inter-
vaI 1.70–2.11%). The relationship between pathology and the Mg:Ca ratio, averaged by calcification, is shown in 
Fig. 5. Although the 6 highest Mg:Ca levels out of 66 calcifications were all in specimens with an invasive diagno-
sis, there was no significant difference between the pathology groups.
The single calcification with a very high Ca:P ratio showed a large difference in magnesium level between the 
low-P and high-P areas within the calcification. The 15 measurements from the low-P areas had a Mg:Ca ratio in 
the range 0.1–1.1% (mean 0.7%), whereas the 12 measurements from the high-P areas had a Mg:Ca ratio in the 
range 1.8–2.7% (mean 2.2%).
Sodium Calcium Ratio. The relationship between pathology and the Na:Ca ratio, averaged by calcification, 
is shown in Fig. 6. Unlike the other two elemental ratios, there is a highly significant difference between groups. 
Treating diagnosis as an ordinal variable, ranked benign < in-situ < invasive, the Na:Ca ratio is positively corre-
lated with diagnosis (p < 0.001 Kendall's tau-b). With the measurements aggregated to a mean specimen level, 
the significance of the correlation becomes p = 0.007. If diagnosis is treated as a binary variable, mean specimen 
sodium level is significantly lower in benign than malignant specimens (p = 0.007 Mann-Whitney U).
Measurements of sodium levels need to be treated with caution. The specimens are immersed in saline 
solutions during fixation, hence at least some of the sodium present might not originate from the calcification. 
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However, the single calcification with areas of low-phosphorus calcified material provides evidence that the 
sodium detected is intrinsic to the apatite phase. As with magnesium, the sodium measurements fell into two 
very distinct groups. The 15 measurements from the low-P areas had a low sodium content, with a Na:Ca ratio in 
the range 0.2–1.5% (mean 0.8%). In contrast, the 12 measurements from the high-P areas had high Na:Ca ratio 
in the range 3.3% to 6.4% (mean 5.1%). As confirmation that this is not an artefact in which the signal from all 
low atomic number elements is suppressed in the low phosphorus areas, or that an inadequately corrected oxygen 
sum peak is masquerading as sodium, the mean weight percentage of oxygen was 49% and 48% in the low and 
high phosphorus regions respectively.
Other Elements. Other elements of interest are potassium, iron, and zinc, since elevated levels of these 
elements have been observed in breast tumour tissue23, 24. Levels of these elements within the calcifications in 
this study were all below detection levels. The absence of potassium is not surprising since K+ substitution for 
Ca2+ in apatite is much less energetically favourable than sodium, due the relatively large size of the potassium 
ion25. This is consistent with the observation that potassium levels in bone are an order of magnitude less than 
sodium26. Zinc levels in bone are a further order of magnitude less than potassium26, and the four-fold enhance-
ment observed in tumour tissue21, 24, to about 7–12 ppm, is unlikely to raise levels in calcifications to a level detect-
able by SEM-EDS. Increased iron levels in tumours are very likely due to increased vascularity, as with zinc, the 
levels in bone and tumour soft tissue are far too small to make this a likely candidate for detection in this study.
Correlation with X-Ray Diffraction Data. The three elemental ratios measured were compared to crys-
tallographic parameters previously measured1 in the 39 calcifications for which both sets of measurements were 
available, and are shown in Table 1. The lattice parameter ‘c’/‘a’ ratio was used since the ‘a’ and ‘c’ parameters are 
strongly negatively correlated in these specimens. Linear regression was conducted with XRD measurements as 
a function of EDS measurements. The p-value for a correlation was adjusted to control the familywise error rate 
for multiple comparisons using the Holm–Bonferroni method. After adjustment, the only significant correlations 
between crystallographic parameters and composition relate to the magnesium calcium ratio. Although the cor-
relations are all weak, domain size, c/a lattice parameter ratio and whitlockite percentage were all significantly 
negatively correlated with magnesium concentration.
Discussion
Calcium Phosphorus ratio. The calcium to phosphorus ratio was of primary interest in this study, since 
if there were a substantial variation with pathology, it would open up the possibility of additional diagnostically 
Figure 1. SEM image of a typical calcification overlaid with EDS elemental maps. The aluminium substrate can 
be seen through the cracks in the calcification resulting from sectioning. (Specimen S44 – pathology details in 
Supplementary Table A).
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Figure 2. SEM image of a highly fragmented calcification. Note the shadowing of the substrate in the Al image. 
(Specimen S59 - pathology details in Supplementary Table A).
Figure 3. SEM image of a calcification with low phosphorus regions corresponding to a non-apatite phase. 
(Specimen S66 – pathology details in Supplementary Table A).
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useful information from mammography using energy discriminating detectors. However, the measured Ca:P 
ratio of calcifications found to lie in a narrow range (interquartile range 1.64 to 1.75), and no significant dif-
ference could be found between the pathology groups. These results do not preclude the possibility that some 
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Figure 4. The Ca:P ratio of calcifications shows no systematic variation with specimen pathology.
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Figure 5. No significant difference in Mg:Ca ratio for calcifications was found between diagnoses.
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Figure 6. The Na:Ca ratio of calcifications in specimens with a benign diagnosis is significantly lower than that 
in specimens categorised as malignant (In-Situ or Invasive).
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diagnostically useful relationship may exist within a particular sub-type of calcifications, but the apparent lack of 
a general relationship limits the appeal of this approach.
The Ca:P ratio in breast calcifications has been measured previously in one small study using SEM-WDS 
(Wavelength Dispersive Spectroscopy)27. This involved three benign and two malignant specimens, with 2–5 
calcified tissue spectra collected per specimen. The overall mean molar Ca:P ratios for benign and malignant 
specimens were 1.64 and 1.67 respectively (weight ratios 2.13 and 2.17), which is very similar to our study.
It has been suggested that the mechanisms involved in the formation of breast calcifications may be similar 
to those involved in the deposition of hydroxyapatite in bone; in particular, bone matrix proteins involved in 
osteoblast mineralisation are also expressed in mammary cells28. Measured values for Ca:P ratio in bone vary 
widely, and have recently been comprehensively reviewed26. The most relevant all-bone study cited is the ICRP-89 
Reference Woman with a Ca:P atomic ratio of 1.63, and a compilation of studies on various bones gave a value of 
1.68. These are very similar to the values found for breast calcifications in this study. Calcifications appear to be 
similar to bone in Ca:P ratio as well as in crystallographic parameters.
The low phosphorus areas in one calcification must consist of a non-apatite phase. The most likely contender 
is calcium oxalate, though without evidence from x-ray diffraction and/or vibrational spectroscopy, this cannot 
be confirmed. Although most calcium oxalate crystals have been reported in association with benign lesions, they 
have also been observed in malignant cases, where they are presumed to be bystanders29. It is also notable that 
this instance occurs within a calcification which also contains regions of hydroxyapatite, whereas there are no 
previous reports of a mixed Type I/II calcification.
Magnesium Calcium ratio. We previously reported an increased level of magnesium whitlockite in malig-
nant specimens compared to benign. We therefore expected to find higher levels of magnesium in the malignant 
specimens. Not only did we find no such correlation between magnesium levels and pathology, but we found a 
statistically significant inverse correlation between Mg:Ca ratio and percentage of magnesium whitlockite, as 
determined by x-ray diffraction.
This initially surprising finding can be explained from the nature of magnesium within calcified tissue. 
Magnesium in bone resides largely on the crystal surface30, 31 or hydration layer32, 33 rather than within the apatite 
lattice. Apatite has been shown to be capable of only very limited magnesium substitution under physiological 
conditions16. Much of the magnesium in calcified tissue can therefore exchange rapidly, and forms the main 
reservoir for buffering extracellular magnesium in the body34, 35. Extracellular levels of magnesium have been 
observed to be, on average, lower than normal in breast cancer36. Even if a calcification initially forms with high 
levels of magnesium, due to high intracellular levels, magnesium associated with hydroxyapatite could rapidly 
decrease towards the lower levels present in the extracellular environment. This is particularly likely given the 
high surface area to volume ratio of a particle the size of a breast calcification. It is also conceivable that at least 
some labile magnesium could leach from calcifications within the specimen through immersion during fixation 
and histological processing.
In contrast to the apatite phase, the magnesium in whitlockite forms an essential stabilising element of the 
crystal lattice37, 38. The presence of whitlockite is therefore an indicator of the local magnesium concentration 
at the time of mineralisation, rather than the time of sampling39. In precipitation experiments where there are 
both carbonate and magnesium ions in solution, it has also been observed that lower pH leads to less magne-
sium incorporation into the apatite lattice for a given magnesium concentration in the solution40. Furthermore, 
at lower pH, the appearance of whitlockite occurs at lower magnesium concentrations40. The pH is, on average, 
likely to be lower in malignant specimens than benign, thus inhibiting incorporation of magnesium into the apa-
tite lattice, and instead favouring whitlockite formation. This offers an explanation for the increased whitlockite 
fraction in malignant specimens. The reported high intracellular41 vs. low extracellular36 levels of magnesium 
in breast cancer would resolve the apparent contradiction that whitlockite percentage appears to be negatively 
correlated with magnesium content.
EDS 
Measurement XRD measurement Coefficient Adjusted R2 p-value
Adjusted 
p-value
Mg:Ca Ratio
Whitlockite % −35.6 0.183 0.004 0.034
Domain Diameter −125 0.165 0.007 0.046
‘c’/‘a’ lattice parameter 
ratio −0.105 0.279 <0.001 0.003
Ca:P Ratio
Whitlockite % 2.73 0.098 0.032 0.158
Domain Diameter −0.0555 −0.028 0.991 1.000
‘c’/‘a’ lattice parameter 
ratio 0.00231 −0.012 0.459 1.000
Na:Ca Ratio
Whitlockite % −1.29 −0.027 0.871 1.000
Domain Diameter 63.1 0.107 0.026 0.154
‘c’/‘a’ lattice parameter 
ratio 0.0366 0.071 0.056 0.222
Table 1. Correlation of elemental ratios measured in this study, with X-ray diffraction measurements made on 
the same 39 calcifications in a previous study.
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Note that high intracellular levels of magnesium could still explain the low levels of carbonate observed in 
calcifications associated with tumours, as previously suggested1, since the carbonate level within the apatite lattice 
is influenced by the magnesium concentration at the time of crystallisation.
Sodium. One of the most interesting and potentially useful observations in this study is the presence of signif-
icantly higher sodium levels in calcifications within malignant specimens. This is consistent with the observation 
that total tissue sodium levels are elevated within breast tumours42, 43. Intracellular levels of sodium are known to 
be elevated within tumour cells17, 18, whereas it is postulated that the extracellular sodium concentration remains 
relatively constant, provided there is exchange with the blood pool42. This suggests a predominantly intracellular 
origin for the calcifications observed in this study. Sodium readily substitutes for calcium in hydroxyapatite, and 
the level of substitution is likely to reflect the sodium concentration at the time of apatite precipitation. It appears 
that this difference survives histological processing, due to the fact that the sodium is substituted within the apa-
tite lattice. If it can be confirmed that all calcifications arising from malignant changes display elevated sodium 
levels, this has potential to indicate malignancy in the vicinity of a needle biopsy specimen, even if malignant cells 
are not contained within the core.
Materials and Methods
Tissue Specimens. This study consisted of further characterisation of the specimens described in a previous 
publication1, together with additional specimens of the same type. These consisted of Formalin Fixed Paraffin 
Embedded (FFPE) core biopsy breast specimens selected from the Gloucestershire Hospitals NHS Foundation 
Trust diagnostic archive. The study was approved by Gloucestershire Local Research Ethics Committee and all 
methods were performed in accordance with relevant guidelines and regulations. Blocks were randomly selected 
from the 2012 archive, subject to the presence of calcifications in the histopathology report, and an unambigu-
ous classification of “B2 - Benign”, “B5a - Ductal Carcinoma In-Situ”, or“B5b - Invasive Carcinoma”44. For the 
purposes of analysis, specimens were also grouped as “Benign” (B2) vs. “Malignant” (B5a or B5b). A summary 
of the histopathology report for each of the specimens analysed is given in Supplementary Information Table A. 
Blocks with radiographic evidence of calcifications near the cut surface were CT-scanned, and the reconstructed 
volumes processed as previously described45 to identify the position of calcifications relative to the tissue outlines 
at the surface of the blocks. A 5 μm slice from each block was mounted on a polished Ø25 mm aluminium alloy 
SEM stub.
X-Ray Microanalysis. Elemental composition was measured using Energy-dispersive X-ray spectroscopy 
(EDS) in a Philips XL30 ESEM with an Oxford Instruments SiLi detector. The working distance was 12 mm, 
and approximately 200,000 total counts were taken per point measurement. A total of 2,789 spectra were col-
lected from 66 calcifications in 31 specimens. Composition was calculated in AZtec 2.1 (Oxford Instruments). 
Measurement of composition in this type of specimen presents several challenges, which must be addressed in 
order to obtain reproducible results.
Charging. It was initially hoped that a 5 μm thick histological section in intimate contact with a polished alu-
minium SEM stub could be analysed under high vacuum without specimen charging, and indeed this proved to 
be the case with wax embedded soft tissue. However, the calcifications were fragmented by the microtome blade, 
frequently resulting in elevated flakes with only an edge in contact with the substrate. As a result, severe charging 
was observed with many calcifications. This could not be eliminated by carbon coating, due to the fragmented 
nature of the surface. Charging was eliminated by operating the SEM in environmental mode, with water vapour 
pressure 93 Pa (0.7 Torr). This also removed the need for carbon coating. Absence of charging was confirmed 
from observation of the Duane-Hunt bremsstrahlung limit. One potential bias introduced by operating in envi-
ronmental mode is scattering of the beam, and consequently contamination of point measurements with signals 
from the ‘skirt’ of scattered electrons. With a working distance of 12 mm and a 20 kV accelerating voltage, only 
about 57% of the electron beam remains unscattered (scattering less than 10−6 Rad)46. In principle, therefore, 
measurements of a calcification could include a substantial contribution from surrounding soft tissue. To assess 
the magnitude of this effect, the typical contribution from soft tissue in biopsy cores containing calcifications was 
measured. Under identical collection conditions, soft tissue counts for phosphorus and calcium were approxi-
mately 2 and 3 orders of magnitude (respectively) lower than the counts from a calcification, and magnesium was 
below the level of detection. Theoretically, therefore, the Ca:P ratio could be underestimated by up to ~0.4% in a 
very small calcification as a result of the contribution from the skirt. In practice, this is substantially lower than 
other sources of variation for these measurements, hence can be disregarded. For verification, measurements on 
a small (~Ø10 μm) unfragmented calcification showed no significant variation in the Ca:P and Mg:Ca ratios with 
pressure over a range of 40–130 Pa (0.3–1.0 Torr).
Specimen Thickness. If the electron beam penetrates through the specimen to the substrate, this complicates 
the calculation of elemental concentrations, particularly if the local thickness varies within the skirt region of 
gas-scattered electrons. This difficulty can be eliminated if the combination of specimen thickness and beam 
energy ensures minimal beam penetration to the substrate. Using cortical bone as an analogue for the calcifica-
tion matrix, the electron penetration depth of an unscattered 20 kV beam into a 5 μm thick slice was calculated 
using winCasino v2.4847. Elemental composition and density of cortical bone were taken from a NIST database48. 
The φ(ρ, z) curve shows that at 20 kV and slice thickness of 5 μm there is negligible penetration of electrons to the 
substrate. A straightforward bulk analysis calculation can therefore be performed.
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Topography. The chemical composition within breast calcifications has been found to be very inhomogenous15, 
hence an area measurement over the whole cut surface of a calcification is an attractive option for measuring the 
average composition. However, as a result of fragmentation by the microtome blade, the calcification surface is 
not smooth and perpendicular to the beam. The local orientation of the surface relative to the electron beam and 
the detector can have a very substantial effect on the measured elemental concentrations. Moreover, this effect is 
not symmetrical; the disproportionate reduction in low energy x-rays from areas tilted away from the detector 
is not compensated by the areas oriented towards the detector, hence simple area averaging over the whole cal-
cification will underestimate the concentration of low atomic number elements. The reduction in overall count 
rate from the areas tilted away from the detector mitigates this effect, but does not eliminate it. There are several 
strategies that can be adopted to correct for these topographic errors.
One option is to measure the peak to local background ratio. Since the background signal originates from the 
same electron interaction volume as the characteristic x-rays, it will be subject to the same absorption effects, 
and hence can be used to correct approximately for topographic errors. A practical problem with this approach 
is that the peak to background ratio in this measurement configuration is typically large (50:1 for calcium in this 
case) thus an excessively long collection time is needed to acquire sufficient background signal to calculate an 
adequately precise peak to background ratio.
Another approach is to take repeat point measurements in multiple specimen orientations, either by rotating 
the specimen around the beam axis, or with the use of multiple detectors. A simpler alternative to obtaining an 
average composition for the calcification involves measurement of multiple points over the calcification surface; if 
the orientation of measurement points in the beam-specimen-detector plane is symmetrically distributed relative 
the specimen normal, then the median measurement will approximate to the median composition with a surface 
orientation normal to the beam axis. This was verified with measurements distributed over the surface of a 70 μm 
spherical particle of synthetic hydroxyapatite. In some cases there was evidence of systematic orientation of flakes 
comprising the calcification, due to the directional cutting action of the microtome blade. A hybrid approach 
was therefore adopted, consisting of measuring multiple points, rotating the specimen by 180°, and measuring 
another set of points. The median and confidence interval of the elemental ratios of interest was calculated for 
the combined set of points using Efron’s nonparametric bias-corrected and accelerated (BCa) bootstrap method 
in R49, 50. Based on the 95% confidence interval, the mean precision of the median for a set of measurements on a 
calcification was ±3.4% for Ca:P ratio, and ±16% for both Mg:Ca and Na:Ca ratios.
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